![](https://themiamientrepreneur.com/wp-content/uploads/2023/12/social-jhqhhG.jpeg)
: EyePoint Pharmaceuticals’ stock soars 212% after company announces positive data for macular degeneration treatment
Read Time:5 Second
EyePoint’s stock is on track for its biggest ever one-day percentage gain in heavy volume.